$IDXX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in IDEXX LABORATORIES INC /DE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in IDEXX LABORATORIES INC /DE. Get notifications about new insider transactions in IDEXX LABORATORIES INC /DE for free.
Page: < prev 1 ... 2 3 4 5 6 7 8 9 10 ... 28 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 20 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Sell | S | 208.54 | 4,700 | 980,133 | 5,762 | 10.5 K to 5.8 K (-44.92 %) |
Feb 20 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Buy | M | 67.85 | 4,700 | 318,895 | 10,462 | 5.8 K to 10.5 K (+81.57 %) |
Feb 20 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Sell | S | 207.80 | 100 | 20,780 | 5,762 | 5.9 K to 5.8 K (-1.71 %) |
Feb 20 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Buy | M | 79.54 | 100 | 7,954 | 5,862 | 5.8 K to 5.9 K (+1.74 %) |
Feb 20 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Sell | S | 207.54 | 2,866 | 594,796 | 5,762 | 8.6 K to 5.8 K (-33.22 %) |
Feb 20 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Buy | M | 79.54 | 2,866 | 227,962 | 8,648 | 5.8 K to 8.6 K (+49.57 %) |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Option Exercise | M | 0.00 | 169 | 0 | 3,183 | |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Option Exercise | M | 0.00 | 212 | 0 | 3,352 | |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Option Exercise | M | 0.00 | 405 | 0 | 3,564 | |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Option Exercise | M | 0.00 | 345 | 0 | 3,969 | |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Option Exercise | M | 0.00 | 282 | 0 | 4,314 | |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Option Exercise | M | 0.00 | 785 | 0 | 4,596 | |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Option Exercise | M | 206.94 | 483 | 99,952 | 483 | |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Option Exercise | M | 206.94 | 7,186 | 1,487,071 | 7,186 | |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Payment of Exercise | F | 206.94 | 428 | 88,570 | 18,678 | 19.1 K to 18.7 K (-2.24 %) |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Buy | M | 0.00 | 169 | 0 | 19,106 | 18.9 K to 19.1 K (+0.89 %) |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Buy | M | 0.00 | 212 | 0 | 18,937 | 18.7 K to 18.9 K (+1.13 %) |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Buy | M | 0.00 | 405 | 0 | 18,725 | 18.3 K to 18.7 K (+2.21 %) |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Buy | M | 0.00 | 345 | 0 | 18,320 | 18 K to 18.3 K (+1.92 %) |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Buy | M | 0.00 | 282 | 0 | 17,975 | 17.7 K to 18 K (+1.59 %) |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | Turner Kathy V | Corporate Vice Pres ... | Option Exercise | M | 0.00 | 211 | 0 | 3,478 | |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | Turner Kathy V | Corporate Vice Pres ... | Option Exercise | M | 0.00 | 212 | 0 | 3,689 | |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | Turner Kathy V | Corporate Vice Pres ... | Option Exercise | M | 0.00 | 221 | 0 | 3,901 | |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | Turner Kathy V | Corporate Vice Pres ... | Option Exercise | M | 0.00 | 188 | 0 | 4,122 | |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | Turner Kathy V | Corporate Vice Pres ... | Option Exercise | M | 0.00 | 906 | 0 | 4,310 | |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | Turner Kathy V | Corporate Vice Pres ... | Option Exercise | M | 206.94 | 483 | 99,952 | 483 | |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | Turner Kathy V | Corporate Vice Pres ... | Option Exercise | M | 206.94 | 8,366 | 1,731,260 | 8,366 | |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | Turner Kathy V | Corporate Vice Pres ... | Payment of Exercise | F | 206.94 | 233 | 48,217 | 3,832 | 4.1 K to 3.8 K (-5.73 %) |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | Turner Kathy V | Corporate Vice Pres ... | Buy | M | 0.00 | 211 | 0 | 4,065 | 3.9 K to 4.1 K (+5.47 %) |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | Turner Kathy V | Corporate Vice Pres ... | Buy | M | 0.00 | 212 | 0 | 3,854 | 3.6 K to 3.9 K (+5.82 %) |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | Turner Kathy V | Corporate Vice Pres ... | Buy | M | 0.00 | 221 | 0 | 3,642 | 3.4 K to 3.6 K (+6.46 %) |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | Turner Kathy V | Corporate Vice Pres ... | Buy | M | 0.00 | 188 | 0 | 3,421 | 3.2 K to 3.4 K (+5.82 %) |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Option Exercise | M | 0.00 | 169 | 0 | 3,591 | |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Option Exercise | M | 0.00 | 212 | 0 | 3,760 | |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Option Exercise | M | 0.00 | 405 | 0 | 3,972 | |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Option Exercise | M | 0.00 | 345 | 0 | 4,377 | |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Payment of Exercise | F | 206.94 | 345 | 71,394 | 5,762 | 6.1 K to 5.8 K (-5.65 %) |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Buy | M | 0.00 | 169 | 0 | 6,107 | 5.9 K to 6.1 K (+2.85 %) |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Buy | M | 0.00 | 212 | 0 | 5,938 | 5.7 K to 5.9 K (+3.70 %) |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Buy | M | 0.00 | 405 | 0 | 5,726 | 5.3 K to 5.7 K (+7.61 %) |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Buy | M | 0.00 | 345 | 0 | 5,321 | 5 K to 5.3 K (+6.93 %) |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 0.00 | 505 | 0 | 7,819 | |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 0.00 | 459 | 0 | 8,324 | |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 0.00 | 811 | 0 | 8,783 | |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 0.00 | 629 | 0 | 9,594 | |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 0.00 | 726 | 0 | 10,223 | |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 0.00 | 2,175 | 0 | 10,949 | |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 206.94 | 483 | 99,952 | 483 | |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 206.94 | 20,753 | 4,294,626 | 20,753 | |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Payment of Exercise | F | 206.94 | 1,612 | 333,587 | 47,496 | 49.1 K to 47.5 K (-3.28 %) |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Buy | M | 0.00 | 505 | 0 | 49,108 | 48.6 K to 49.1 K (+1.04 %) |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Buy | M | 0.00 | 459 | 0 | 48,603 | 48.1 K to 48.6 K (+0.95 %) |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Buy | M | 0.00 | 811 | 0 | 48,144 | 47.3 K to 48.1 K (+1.71 %) |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Buy | M | 0.00 | 629 | 0 | 47,333 | 46.7 K to 47.3 K (+1.35 %) |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Buy | M | 0.00 | 726 | 0 | 46,704 | 46 K to 46.7 K (+1.58 %) |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JAY | Executive Vice Pres ... | Option Exercise | M | 0.00 | 505 | 0 | 7,516 | |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JAY | Executive Vice Pres ... | Option Exercise | M | 0.00 | 459 | 0 | 8,021 | |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JAY | Executive Vice Pres ... | Option Exercise | M | 0.00 | 737 | 0 | 8,480 | |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JAY | Executive Vice Pres ... | Option Exercise | M | 0.00 | 471 | 0 | 9,217 | |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JAY | Executive Vice Pres ... | Option Exercise | M | 0.00 | 403 | 0 | 9,688 | |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JAY | Executive Vice Pres ... | Option Exercise | M | 0.00 | 2,175 | 0 | 10,091 | |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JAY | Executive Vice Pres ... | Option Exercise | M | 206.94 | 483 | 99,952 | 483 | |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JAY | Executive Vice Pres ... | Option Exercise | M | 206.94 | 20,753 | 4,294,626 | 20,753 | |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JAY | Executive Vice Pres ... | Payment of Exercise | F | 206.94 | 762 | 157,688 | 23,212 | 24 K to 23.2 K (-3.18 %) |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JAY | Executive Vice Pres ... | Buy | M | 0.00 | 505 | 0 | 23,974 | 23.5 K to 24 K (+2.15 %) |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JAY | Executive Vice Pres ... | Buy | M | 0.00 | 459 | 0 | 23,469 | 23 K to 23.5 K (+1.99 %) |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JAY | Executive Vice Pres ... | Buy | M | 0.00 | 737 | 0 | 23,010 | 22.3 K to 23 K (+3.31 %) |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JAY | Executive Vice Pres ... | Buy | M | 0.00 | 471 | 0 | 22,273 | 21.8 K to 22.3 K (+2.16 %) |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JAY | Executive Vice Pres ... | Buy | M | 0.00 | 403 | 0 | 21,802 | 21.4 K to 21.8 K (+1.88 %) |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Corporate Vice Pres ... | Option Exercise | M | 0.00 | 197 | 0 | 2,956 | |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Corporate Vice Pres ... | Option Exercise | M | 0.00 | 212 | 0 | 3,153 | |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Corporate Vice Pres ... | Option Exercise | M | 0.00 | 221 | 0 | 3,365 | |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Corporate Vice Pres ... | Option Exercise | M | 0.00 | 188 | 0 | 3,586 | |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Corporate Vice Pres ... | Option Exercise | M | 0.00 | 242 | 0 | 3,774 | |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Corporate Vice Pres ... | Option Exercise | M | 0.00 | 906 | 0 | 4,016 | |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Corporate Vice Pres ... | Option Exercise | M | 206.94 | 483 | 99,952 | 483 | |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Corporate Vice Pres ... | Option Exercise | M | 206.94 | 8,366 | 1,731,260 | 8,366 | |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Corporate Vice Pres ... | Sell | S | 208.00 | 971 | 201,968 | 3,146 | 4.1 K to 3.1 K (-23.59 %) |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Corporate Vice Pres ... | Payment of Exercise | F | 206.94 | 324 | 67,049 | 4,117 | 4.4 K to 4.1 K (-7.30 %) |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Corporate Vice Pres ... | Buy | M | 0.00 | 197 | 0 | 4,441 | 4.2 K to 4.4 K (+4.64 %) |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Corporate Vice Pres ... | Buy | M | 0.00 | 212 | 0 | 4,244 | 4 K to 4.2 K (+5.26 %) |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Corporate Vice Pres ... | Buy | M | 0.00 | 221 | 0 | 4,032 | 3.8 K to 4 K (+5.80 %) |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Corporate Vice Pres ... | Buy | M | 0.00 | 188 | 0 | 3,811 | 3.6 K to 3.8 K (+5.19 %) |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Corporate Vice Pres ... | Buy | M | 0.00 | 242 | 0 | 3,623 | 3.4 K to 3.6 K (+7.16 %) |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Option Exercise | M | 0.00 | 1,774 | 0 | 0 | |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Option Exercise | M | 206.94 | 483 | 99,952 | 483 | |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Option Exercise | M | 206.94 | 78,170 | 16,176,500 | 78,170 | |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Payment of Exercise | F | 206.94 | 824 | 170,519 | 1,032,272 | 1 M to 1 M (-0.08 %) |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Buy | M | 0.00 | 1,774 | 0 | 1,033,096 | 1 M to 1 M (+0.17 %) |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | SZOSTAK M ANNE | Director | Option Exercise | M | 47.53 | 5,906 | 280,712 | 0 | |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | SZOSTAK M ANNE | Director | Sell | S | 208.96 | 5,906 | 1,234,091 | 3,416 | 9.3 K to 3.4 K (-63.36 %) |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | SZOSTAK M ANNE | Director | Gift | G | 0.00 | 5,906 | 0 | 9,322 | 3.4 K to 9.3 K (+172.89 %) |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | SZOSTAK M ANNE | Director | Gift | G | 0.00 | 5,906 | 0 | 584 | 6.5 K to 584 (-91.00 %) |
Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | SZOSTAK M ANNE | Director | Buy | M | 47.53 | 5,906 | 280,712 | 6,490 | 584 to 6.5 K (+1,011.30 %) |
Feb 07 2019 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Sell | S | 209.08 | 997 | 208,454 | 17,693 | 18.7 K to 17.7 K (-5.33 %) |
Feb 07 2019 | IDXX | IDEXX LABORATORIES ... | Kingsley Lawrence D | Director | Buy | P | 208.68 | 2,405 | 501,875 | 7,403 | 5 K to 7.4 K (+48.12 %) |
Feb 07 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Option Exercise | M | 43.71 | 15,905 | 695,208 | 0 | |
Feb 07 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Option Exercise | M | 43.71 | 15,905 | 695,208 | 15,905 | |
Feb 07 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Option Exercise | M | 43.71 | 15,904 | 695,164 | 31,810 | |
Feb 07 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Sell | S | 207.17 | 2,998 | 621,100 | 1,031,322 | 1 M to 1 M (-0.29 %) |
Feb 07 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Sell | S | 206.54 | 8,800 | 1,817,578 | 1,034,320 | 1 M to 1 M (-0.84 %) |
Feb 07 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Sell | S | 205.53 | 4,107 | 844,110 | 1,043,120 | 1 M to 1 M (-0.39 %) |
Feb 07 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Buy | M | 43.71 | 15,905 | 695,208 | 1,047,227 | 1 M to 1 M (+1.54 %) |
Feb 07 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Sell | S | 208.53 | 7,428 | 1,548,936 | 1,031,322 | 1 M to 1 M (-0.72 %) |
Feb 07 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Sell | S | 207.77 | 8,477 | 1,761,298 | 1,038,750 | 1 M to 1 M (-0.81 %) |
Feb 07 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Buy | M | 43.71 | 15,905 | 695,208 | 1,047,277 | 1 M to 1 M (+1.54 %) |
Feb 07 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Sell | S | 206.14 | 100 | 20,614 | 1,031,322 | 1 M to 1 M (-0.01 %) |
Feb 07 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Sell | S | 205.81 | 6,041 | 1,243,270 | 1,031,422 | 1 M to 1 M (-0.58 %) |
Feb 07 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Sell | S | 204.75 | 8,045 | 1,647,225 | 1,037,463 | 1 M to 1 M (-0.77 %) |
Feb 07 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Sell | S | 203.75 | 1,718 | 350,050 | 1,045,508 | 1 M to 1 M (-0.16 %) |
Feb 07 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Buy | M | 43.71 | 15,904 | 695,164 | 1,047,226 | 1 M to 1 M (+1.54 %) |
Feb 01 2019 | IDXX | IDEXX LABORATORIES ... | Vandebroek Sophie V. | Director | Grant | A | 207.68 | 90 | 18,691 | 9,027 | 8.9 K to 9 K (+1.01 %) |
Feb 01 2019 | IDXX | IDEXX LABORATORIES ... | Kingsley Lawrence D | Director | Grant | A | 207.68 | 120 | 24,922 | 4,998 | 4.9 K to 5 K (+2.46 %) |
Feb 01 2019 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Grant | A | 207.68 | 29 | 6,023 | 2,741 | 2.7 K to 2.7 K (+1.07 %) |
Feb 01 2019 | IDXX | IDEXX LABORATORIES ... | ESSIG STUART | Director | Grant | A | 207.68 | 90 | 18,691 | 568 | 478 to 568 (+18.83 %) |
Jan 03 2019 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 0.00 | 2,820 | 0 | 8,774 | |
Jan 03 2019 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Payment of Exercise | F | 186.02 | 1,006 | 187,136 | 45,978 | 47 K to 46 K (-2.14 %) |
Jan 03 2019 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Buy | M | 0.00 | 2,820 | 0 | 48,984 | 46.2 K to 49 K (+6.11 %) |
Dec 07 2018 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JAY | Executive Vice Pres ... | Option Exercise | M | 0.00 | 961 | 0 | 7,916 | |
Dec 07 2018 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JAY | Executive Vice Pres ... | Payment of Exercise | F | 196.80 | 446 | 87,773 | 21,374 | 21.8 K to 21.4 K (-2.04 %) |
Dec 07 2018 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JAY | Executive Vice Pres ... | Buy | M | 0.00 | 961 | 0 | 21,820 | 20.9 K to 21.8 K (+4.61 %) |
Nov 29 2018 | IDXX | IDEXX LABORATORIES ... | HENDERSON REBECCA M | Director | Option Exercise | M | 22.02 | 7,504 | 165,257 | 0 | |
Nov 29 2018 | IDXX | IDEXX LABORATORIES ... | HENDERSON REBECCA M | Director | Sell | S | 194.92 | 3,504 | 682,992 | 18,696 | 22.2 K to 18.7 K (-15.78 %) |
Nov 29 2018 | IDXX | IDEXX LABORATORIES ... | HENDERSON REBECCA M | Director | Buy | M | 22.02 | 7,504 | 165,257 | 22,200 | 14.7 K to 22.2 K (+51.06 %) |
Nov 16 2018 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Gift | G | 0.00 | 28,000 | 0 | 1,035,497 | 1.1 M to 1 M (-2.63 %) |
Nov 07 2018 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Sell | S | 201.28 | 3,313 | 666,823 | 4,951 | 8.3 K to 5 K (-40.09 %) |
Nov 01 2018 | IDXX | IDEXX LABORATORIES ... | Vandebroek Sophie V. | Director | Grant | A | 210.22 | 89 | 18,710 | 8,937 | 8.8 K to 8.9 K (+1.01 %) |
Nov 01 2018 | IDXX | IDEXX LABORATORIES ... | Kingsley Lawrence D | Director | Grant | A | 210.22 | 119 | 25,016 | 4,878 | 4.8 K to 4.9 K (+2.50 %) |
Nov 01 2018 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Grant | A | 210.22 | 28 | 5,886 | 2,712 | 2.7 K to 2.7 K (+1.04 %) |
Nov 01 2018 | IDXX | IDEXX LABORATORIES ... | ESSIG STUART | Director | Grant | A | 210.22 | 89 | 18,710 | 478 | 389 to 478 (+22.88 %) |
Sep 04 2018 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Option Exercise | M | 0.00 | 1,129 | 0 | 4,722 | |
Sep 04 2018 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Payment of Exercise | F | 254.04 | 524 | 133,117 | 8,239 | 8.8 K to 8.2 K (-5.98 %) |
Sep 04 2018 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Buy | M | 0.00 | 1,129 | 0 | 8,763 | 7.6 K to 8.8 K (+14.79 %) |
Sep 04 2018 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Gift | G | 0.00 | 40,000 | 0 | 138,000 | 98 K to 138 K (+40.82 %) |
Sep 04 2018 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Gift | G | 0.00 | 40,000 | 0 | 1,063,469 | 1.1 M to 1.1 M (-3.62 %) |
Aug 30 2018 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Option Exercise | M | 43.71 | 30,000 | 1,311,300 | 47,714 | |
Aug 30 2018 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Buy | M | 43.71 | 30,000 | 1,311,300 | 1,103,469 | 1.1 M to 1.1 M (+2.79 %) |
Aug 23 2018 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Option Exercise | M | 45.84 | 2,180 | 99,931 | 0 | |
Aug 23 2018 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Option Exercise | M | 43.71 | 2,286 | 99,921 | 0 | |
Aug 23 2018 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Option Exercise | M | 43.71 | 11,372 | 497,070 | 0 | |
Aug 23 2018 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Buy | M | 45.84 | 2,180 | 99,931 | 18,640 | 16.5 K to 18.6 K (+13.24 %) |
Aug 23 2018 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Buy | M | 43.71 | 2,286 | 99,921 | 16,460 | 14.2 K to 16.5 K (+16.13 %) |
Aug 23 2018 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Sell | S | 242.71 | 11,372 | 2,760,072 | 14,174 | 25.5 K to 14.2 K (-44.52 %) |
Aug 23 2018 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Buy | M | 43.71 | 11,372 | 497,070 | 25,546 | 14.2 K to 25.5 K (+80.23 %) |
Aug 23 2018 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Option Exercise | S | 141.60 | 2,219 | 314,210 | 8,167 | |
Aug 23 2018 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Option Exercise | M | 67.85 | 9,400 | 637,790 | 12,627 | |
Aug 23 2018 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Sell | S | 245.06 | 3,264 | 799,887 | 7,634 | 10.9 K to 7.6 K (-29.95 %) |
Aug 23 2018 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Sell | S | 244.15 | 2,806 | 685,089 | 10,898 | 13.7 K to 10.9 K (-20.48 %) |
Aug 23 2018 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Sell | S | 243.36 | 5,549 | 1,350,399 | 13,704 | 19.3 K to 13.7 K (-28.82 %) |
Aug 23 2018 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Buy | M | 141.60 | 2,219 | 314,210 | 19,253 | 17 K to 19.3 K (+13.03 %) |